Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES

Similar documents
Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES

Drug Name Description of Change Formulary Coverage Formulary Alternative(s)

Pharmacy and Therapeutics (P&T) Committee Provider Update

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

NOTIFICATION OF FORMULARY CHANGES

2018 Formulary Update

2018 CareOregon Advantage Part D Formulary Changes

September 2018 Pharmacy & Therapeutics Committee Decisions

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)

You ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.

Health Partners Medicare Special 2018 Formulary Changes

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

2018 Medicare Part D Formulary Change

2018 Formulary Update

2014 Step Therapy Criteria (List of Step Therapy Criteria)

2018 Medicare Part D Formulary Change

Quarterly pharmacy formulary change notice

Pharmacy and Therapeutics (P&T) Committee Provider Update

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum

Pharmacy and Therapeutics (P&T) Committee Provider Update

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria

During non-business hours, your call will be answered by our automated phone system. A representative will return your call the next business day.

January 2018 Pharmacy & Therapeutics Committee Decisions

Memorial Hermann Advantage HMO February 2019 Formulary Addendum

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

Quarterly pharmacy formulary change notice

Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.

Step Therapy Requirements

Health Partners Medicare Special Formulary Updates

Added, Removed or Changed. Added, Removed or Changed

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

2018 Formulary Update

Alprazolam 0.25mg, 0.5mg, 1mg tablets

PPHP 2017 Formulary 2017 Step Therapy Criteria

Quarterly pharmacy formulary change notice

Aetna Better Health of Illinois Medicaid Formulary Updates

Step Therapy Requirements

UPHP Advantage (HMO) (H ) and UPHP Choice (HMO) (H ) Updates

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

Quarterly pharmacy formulary change notice

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Quarterly pharmacy formulary change

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

Pharmacy and Therapeutics (P&T) Committee Provider Update

FIRST QUARTER 2018 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES

Quarterly pharmacy formulary change notice

ACYCLOVIR OINT (CCHP2017)

TABLE OF CONTENTS (Click on a link below to view the section.)

HEALTH SHARE/PROVIDENCE (OHP)

Health Partners Medicare Prime 2019 Formulary Changes

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred

Updates to your prescription benefits

Quarterly pharmacy formulary change notice

Step Therapy Requirements. Effective: 11/01/2018

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

ACYCLOVIR OINT (CCHP2017)

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2019 Formulary Update

BlueLink TPA FlexRx Updates

2018 Formulary Notice of Change Prescription Drug Plans

Quarterly pharmacy formulary change notice

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

Partners Notice of Change March 2017

ACYCLOVIR OINT (CCHP2017)

Step Therapy Requirements. Effective: 05/01/2018

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)

P&T/Formulary Committee Actions (1Q18)

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

Oregon Health Plan prescription benefit updates

Quarterly pharmacy formulary change notice

Step Therapy Medications

Quarterly pharmacy formulary change notice

EFFECTIVE 01/04/2019. pimecrolimus 1 % cream (g) - Added to Tier 1 - ST Added: TOPICAL IMMUNOMODULATORS

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred

Medicare Part D 2017 Formulary Changes Service To Senior

Updates to your prescription benefits

Quarterly pharmacy formulary change notice

Transcription:

NOTIFICATION OF FORMULARY CHANGES The following summary describes changes to the 2017 Presbyterian Individual and Family Metal Plan/Employer Group Metal Plan Formularies effective 2018. For the most recent list of drugs, information on obtaining a coverage determination or exception, or other questions, please contact the Presbyterian Customer Service Center. You can reach them Monday through Friday from 8:00 a.m. to 5:00 p.m. Phone: (505) 923-5678 or 1-855-356-2219 TTY: 711 Online: www.phs.org 01/15/2018 Aliqopa (copanlisib HCL for IV solution) 60 mg vial 01/15/2018 Alphagan P (brimonidine tartrate) 0.1% ophthalmic solution 01/15/2018 Aristada (aripiprazole lauroxil) 441 mg, 662 mg, 882 mg, and 1064 mg extended release suspension for IM injection Formulary addition MB, PA ST requirement added Tier 2, ST brimonidine tartrate 0.2% ophthalmic solution PA requirement removed Tier 4, SP 01/15/2018 Austedo (deutetrabenazine) 6 mg, 9 mg, 12 mg tablets MPC011711 Page 1 of 11 Updated 04/30/2018

Presbyterian Health Plan, Inc. 01/15/2018 Benlysta (belimumab) for injection for subcutaneous use 200 mg/ml single-dose prefilled autoinjector and single-dose prefilled syringe 01/15/2018 Besponsa (inotuzumab ozogamicin) injection for IV infusion 0.9 mg single-dose vial 01/15/2018 fenofibrate (generic for Tricor ) 48 mg and 145 mg tablets 01/15/2018 guanfacine ER tablets (generic for Intuniv ) 1 mg, 2 mg, 3 mg, 4 mg, SP Formulary addition MB, PA Formulary addition Tier 1 Formulary addition Tier 1, QL 01/15/2018 Humulin R U-500 (insulin human injection) Moved from Tier 3 to Tier 4 Tier 4, ST, QL 01/15/2018 Kisqali Femara Co-Pack (ribociclib; letrozole) 200/2.5 mg tablets 01/15/2018 Lynparza (olaparib) 100 mg and 150 mg tablets 01/15/2018 Matulane (procarbazine) 50 mg capsules Moved from Tier 2 to Tier 4 Tier 4, PA, SP MPC011711 Page 2 of 11 Updated 04/30/2018

Presbyterian Health Plan, Inc. 01/15/2018 Restasis MultiDose (cyclosporine ophthalmic emulsion) 0.05% 5.5 ml multidose bottle 01/15/2018 tetrabenazine (generic for Xenazine ) 12.5 mg and 25 mg tablets 03/01/2018 Alecensa (alectinib) 150 mg capsules Formulary addition Tier 3, PA, QL, SP 03/01/2018 alfuzosin extended-release (generic for Uroxatral) 10 mg tablets 03/01/2018 armodafinil (generic for Nuvigil) 50 mg, 200 mg, and 250 mg tablets (moved from Tier 3 to Tier 1) (moved from Tier 3 to Tier 1) 150 mg tablets removed from formulary Tier 1, QL Tier 1, PA, QL (50 mg, 200 mg, and 250 mg tablets only) 03/01/2018 Bydureon BCISE (exenatide extended-release) injectable suspension 2 mg/0.85 ml auto-injector Formulary addition Tier 2, ST, QL 03/01/2018 Calquence (acalabrutinib) 100 mg capsules MPC011711 Page 3 of 11 Updated 04/30/2018

03/01/2018 Fiasp (insulin aspart injection) 100 units/ml, 10 ml vial and 3 ml FlexTouch pen 03/01/2018 glatiramer acetate 40 mg/ml (generic for Copaxone 40 mg/ml) Formulary addition Tier 2, QL Formulary addition Tier 4, ST, QL, SP Glatopa 20 mg/ml (glatiramer acetate) Tier 4, QL, SP 03/01/2018 Heplisav-B [Hepatitis B Vaccine (Recombinant), Adjuvanted] Solution for intramuscular injection 03/01/2018 Jeluca (dolutegravir and rilpivirine) 50-25 mg tablets Formulary addition $0, QL, AL Formulary addition Tier 4, QL 03/01/2018 KedRAB Rabies Immune Globulin (Human) Solution for intramuscular injection Formulary addition MB 03/01/2018 modafinil (generic for Provigil) 100 mg and 200 mg talets (moved from Tier 4 to Tier 1) Tier 1, PA, QL 03/01/2018 Ocrevus (ocrelizumab) 30 mg/ml intravenous solution Specialty Pharmacy mandated MB, PA, SP MPC011711 Page 4 of 11 Updated 04/30/2018

03/01/2018 QVAR RediHaler (beclomethasone dipropionate HFA) Formulary addition Tier 3, PA Asmanex HFA (mometason furoate) 100 mcg/act or 200 mcg/act metered dose inhaler - 40 mcg/actuation and 80 mcg/actuation Tier 2 Flovent Diskus(fluticasone propionate) 50 breath activated inhalation aerosol mcg/inhalation, 100 mcg/inhalation, or 250 mcg/inhalation dry powder inhaler - Tier 2 Flovent HFA (fluticasone propionate) 44 mcg/act, 110 mcg/act, or 220 mcg/act metered dose inhaler Tier 2 Pulmicort Flexhaler (budesonide) 90 mcg/act and 180 mcg/act Tier 3 03/01/2018 Sensipar (cinacalcet) Tier 4, PA 30 mg, 60 mg, 90 mg tablets (moved from Tier 3 to Tier 4) 03/01/2018 Shingrix (zoster vaccine recombinant, Formulary addition $0, QL, AL adjuvanted) 03/01/2018 timolol maleate (generic for Istalol) 0.5% ophthalmic solution (once daily) (moved from Tier 2 to Tier 3) Tier 3 timolol maleate 0.25% and 0.5% ophthalmic solution (generic for Timoptic) - Tier 1 03/01/2018 Vyxeos (daunorubicin and Formulary addition MB, PA, QL cytarabine) 44 mg/100 mg for intravenous use 03/01/2018 Xeljanz XR (tofacitinib), SP 11 mg extended-release tablets 03/01/2018 Zostavax (varicella virus vaccine) PA requirement added $0, PA, QL, AL 06/01/2018 acitretin (generic for Soriatane ) 10 mg, 17.5 mg, and 25 mg capsules QL updated Tier 4, PA, QL, SP MPC011711 Page 5 of 11 Updated 04/30/2018

06/01/2018 Afstyla [antihemophilic factor Formulary addition MB, SP (recombinant), single chain] 250, 500, 1000, 1500, 2000, 2500, or 3000 IU 06/01/2018 alogliptin/pioglitazone (generic for Oseni) Formulary addition Tier 2, ST, QL 12.5-15 mg, 12.5-30 mg, 12.5-45 mg, 25-15 mg, 25-30 mg, 25-45 mg tablets 06/01/2018 alprazolam extended- release (generic for Formulary addition Tier 3, QL Xanax XR) 0.5 mg, 1 mg, 2 mg, and 3 mg tablets 06/01/2018 Alunbrig (brigatinib) 90 mg and 180 mg tablets, 90 & 180 mg therapy pack 06/01/2018 aripiprazole (generic for Abilify ) PA requirement removed Tier 1, QL 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg tablets (moved from Tier 4 to Tier 1) 06/01/2018 Biktarvy (bictegravir, emtricitabine, and Formulary addition Tier 4, QL tenofovir alafenamide) 50-200-25 mg tablets 06/01/2018 Bosulif (bosutinib) Formulary addition (400 mg tablet) Tier 4, PA, QL, SP 100 mg, 400 mg, 500 mg tablets PA requirements updated 06/01/2018 Cabometyx (cabozantinib) PA requirements updated Tier 4, PA, QL, SP 20 mg, 40 mg, and 20 mg tablets 06/01/2018 celecoxib (generic for Celebrex ) 50 mg, 100 mg, 200 mg, and 400 mg capsules (moved from Tier 3 to Tier 1) Tier 1, QL MPC011711 Page 6 of 11 Updated 04/30/2018

06/01/2018 Cimetidine oral solution 300 mg/5 ml (moved from Tier 1 to Tier 2) Tier 2 cimetidine 200 mg, 300 mg, 400 mg and 800 mg oral tablets Tier 1 famotidine 20 mg and 40 mg oral tablets Tier 1 ranitidine 15 mg/ml, 75 mg/5 ml and 150 mg/10 ml oral syrup Tier 1 randitidine 150 mg and 300 mg oral tablets Tier 1 06/01/2018 Cinvanti (aprepitant) Formulary addition MB, PA 130 mg/18 ml injectable emulsion 06/01/2018 clindamycin 1% topical gel and lotion QL added Tier 1, QL (generic for Cleocin T ) 06/01/2018 Cough and cold medications containing codeine or hydrocodone AL added Cough and cold medications containing codeine or hydrocodone will not be covered for members < 18 years of age. See formulary listing for complete formulary coverage information for cough and cold medications containing codeine or hydrocodone. 06/01/2018 Codeine containing medications used for the treatment of pain PA requirement added for members 12 to 18 years of age Codeine containing medications are not covered for members < 12 years of age. PA required for patients 12 to 18 years of age. See formulary for complete formulary coverage information for codeine containing medications. 06/01/2018 duloxetine (generic for Cymbalta ) 60 mg capsules QL updated Tier 1, QL MPC011711 Page 7 of 11 Updated 04/30/2018

06/01/2018 Eloctate [antihemophilic factor (recombinant), Fc fusion protein] 250, 500, 750, 1000, 1500, 2000, 3000, Formulary removal Non-formulary Nuwiq [antihemophilic factor (recombinant)], 250, 500, 1000, 2000, 2500, 3000 and 4000 IU - MB, SP 4000, 5000, and 6000 IU 06/01/2018 Enbrel Mini (etanercept) for injection, SP 50 mg/ml single-dose prefilled cartridge for use with the AutoTouch reusable auto injector only 06/01/2018 enoxaparin (generic for Lovenox ) 30 mg/0.3 ml, 40 mg/0.4 ml, 60 mg/0.6 ml, 80 mg/0.8 ml, 100 mg/1 ml, 120 PA requirement added for quantities exceeding plan quantity limits Tier 1, QL* *PA required for amounts exceeding QL mg/0.8 ml, and 150 mg/1 ml prefilled syringes 06/01/2018 Erleada (apalutamide) 60 mg tablets 06/01/2018 Fanapt (iloperidone) 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg tablets and titration pack from ST to PA Tier 4, PA, QL 06/01/2018 Granix (tbo-filgrastim) 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes 06/01/2018 Iclusig (ponatinib) 15 mg and 45 mg tablets 06/01/2018 Imbruvica (ibrutinib) 140 mg, 280 mg, 420 mg and 560 mg tablets packaged as a 4-week supply 06/01/2018 Imfinzi (durvalumab) injection for intravenous use, 120/2.4 ml and 500 mg/10 ml solution in a single-dose vial Formulary removal Non-formulary Zarxio (filgrastim-sndz), 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes MB, PA PA requirements updated Tier 4, PA, QL, SP Formulary addition MB, PA MPC011711 Page 8 of 11 Updated 04/30/2018

06/01/2018 Isentress (raltegravir) QL updated Tier 2, QL 100 mg chewable tablets 06/01/2018 Kalydeco (ivacaftor), SP 150 mg tablets; 50 mg and 75 mg oral granules 06/01/2018 Kovaltry [antihemophilic factor Formulary addition MB, SP (recombinant)] 250, 500, 1000, 2000, and 3000 IU 06/01/2018 lidocaine 5% transdermal patch (generic PA requirement removed Tier 3, QL for Lidoderm ) 06/01/2018 Nebupent (pentamadine isethionate) (moved from Tier 1 to Tier 3) Tier 3, QL, SP inhalation powder for solution 300 mg/ml 06/01/2018 Neupogen (filgrastim) injection 300 mcg/0.5 ml and 480 mcg/0.8 ml Formulary removal Non-formulary Zarxio (filgrastim-sndz), 300 mcg/0.5 ml and 480 mcg/0.8 ml prefilled syringes MB, PA 06/01/2018 Nuvaring (ethinyl estradiol/etonogestrel) 11.7-2.7 mg vaginal ring AL added $0, ST, QL, AL (maximum age: 55 years) 06/01/2018 Nuwiq [antihemophilic factor Formulary addition MB, SP (recombinant)] 250, 500, 1000, 2000, 2500, 3000 and 4000 IU 06/01/2018 Orkambi (lumacaftor/ivacaftor), SP 200-125 mg tablets 06/01/2018 Paxil (paroxetine) PA requirement added Tier 3, PA, QL 10 mg/5 ml oral suspension QL added (moved from Tier 2 to Tier 3) 06/01/2018 sevelamer (generic for Renvela ) 800 mg tablet (moved from Tier 1 to Tier 4) Tier 4 MPC011711 Page 9 of 11 Updated 04/30/2018

06/01/2018 Sprycel (dasatinib) 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg tablets 06/01/2018 Symdeko (tezacaftor/ivacaftor tablets; ivacaftor tablets) 100-150 mg and 150 mg tablets 06/01/2018 Symfi Lo (efavirenz, lamivudine and tenofovir disoproxil fumarate) 400-300-300 mg tablets 06/01/2018 Tasigna (nilotinib) 150 mg and 200 mg capsules PA requirements updated Tier 4, PA, QL, SP, SP Formulary addition Tier 4, QL PA requirements updated Tier 4, PA, QL, SP 06/01/2018 Tramadol containing medications PA requirement added for members 12 to 18 years of age Tramadol containing medications are not covered for members < 12 years of age. PA required for patients 12 to 18 years of age. See formulary for complete coverage information for tramadol containing medications. 06/01/2018 Trogarzo (ibalizumab-uiyk) injection, for intravenous use 200 mg/1.33 ml in a single dose vial 06/01/2018 vancomycin (generic for Vancocin ) 125 mg capsules Formulary addition MB from PA to ST Tier 3, ST, QL metronidazole 500 mg tablets Tier 1 06/01/2018 vancomycin (generic for Vancocin ) 250 mg capsules PA requirements updated Tier 3, PA, QL metronidazole 500 mg tablets Tier 1 MPC011711 Page 10 of 11 Updated 04/30/2018

06/01/2018 Verzenio (abemaciclib) 50 mg, 100 mg, 150 mg, and 200 mg tablets. 06/01/2018 Xgeva (denosumab) injection for subcutaneous use, 120 mg/1.7 ml (70 mg/ml) solution in a single-dose vial 06/01/2018 Xifaxan (rifaxamin) 200 mg and 550 mg tablets 06/01/2018 Xigduo XR (dapagliflozin/metformin) 2.5-1000 mg, 5-500 mg, 5-1000 mg, 10-500 mg, and 10-1000 mg tablets PA requirements updated MB, PA, SP PA requirements updated Tier 4, PA, QL Formulary addition Tier 2, ST, QL 06/01/2018 Xulane (norelgestromin/ethinyl estradiol) 150/35 mcg/day patch AL added $0, ST, QL, AL (maximum age: 55 years) Learn more about Presbyterian s Nondiscrimination Notice and Interpreter Services. MPC011711 Page 11 of 11 Updated 04/30/2018